
Opinion|Videos|May 30, 2024
Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks
The panel offers comprehensive insights on adapting narcolepsy treatments for patients who experience adverse effects, achieve partial response, or have a history of substance abuse.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
2
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
3
Neurosterix Announces Phase 1 Study of NTX-253 for Schizophrenia
4
Stress in Sports: What It Really Means and How to Discuss With Athletes
5
















